These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26646011)

  • 21. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
    PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single Nucleotide Polymorphisms in miR-149 (rs2292832) and miR-101-1 (rs7536540) Are Not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
    Pratedrat P; Sopipong W; Makkoch J; Praianantathavorn K; Chuaypen N; Tangkijvanich P; Payungporn S
    Asian Pac J Cancer Prev; 2015; 16(15):6457-61. PubMed ID: 26434859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C.
    Selitsky SR; Baran-Gale J; Honda M; Yamane D; Masaki T; Fannin EE; Guerra B; Shirasaki T; Shimakami T; Kaneko S; Lanford RE; Lemon SM; Sethupathy P
    Sci Rep; 2015 Jan; 5():7675. PubMed ID: 25567797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
    Kim GA; Han S; Kim HD; An J; Lim YS
    J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.
    Lendvai G; Jármay K; Karácsony G; Halász T; Kovalszky I; Baghy K; Wittmann T; Schaff Z; Kiss A
    World J Gastroenterol; 2014 Nov; 20(41):15343-50. PubMed ID: 25386083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients.
    van der Ree MH; Jansen L; Kruize Z; van Nuenen AC; van Dort KA; Takkenberg RB; Reesink HW; Kootstra NA
    J Infect Dis; 2017 May; 215(9):1421-1429. PubMed ID: 28368488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
    Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
    Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
    Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B.
    Riazalhosseini B; Mohamed R; Apalasamy YD; Langmia IM; Mohamed Z
    Rev Soc Bras Med Trop; 2017; 50(2):161-166. PubMed ID: 28562750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
    Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.